Skip to main content
Clinical Trials/JPRN-UMIN000030620
JPRN-UMIN000030620
Completed
未知

A randomized controlled trial of cognitive behavioral therapy for irritable bowel syndrome using complementary psychoeducational video - A randomized controlled trial of the cognitive behavioral therapy for irritable bowel syndrome

Tohoku University0 sites33 target enrollmentDecember 28, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Irritable bowel syndrome
Sponsor
Tohoku University
Enrollment
33
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 28, 2017
End Date
February 20, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Person in whom organic disease is suggested by the presence of warning symptoms\*. 2\.Persons with a history of or concomitant inflammatory bowel disease, malignant tumor, or other bowel disease which could cause the current bowel symptoms. 3\.Persons suffering from major psychiatric disease, such as psychotic disorders, bipolar disorder, substance abuse\-related disorders, eating disorders, obsessive and compulsive disorders,or PTSD (persons with anxiety disorders, somatic symptom and related disorders and depression without suicidal ideation are not excluded) 4\.Persons with antisocial personality disorders. 5\.Persons observed to have significant suicidal ideation at screening. 6\.Persons with another past or present psychiatric or physical disease that is likely to interfere with continuation and evaluation of the study. 7\. Persons experiencing any other type of marked chronic pain. 8\.Those taking narcotic analgesics. 9\.Persons who anticipate difficulty attending 10 sessions as an outpatient during the 16\-week CBT implementation period. 10\.Those who have previously received structured individual CBT. 11\.Those for whom verbal and written communication in Japanese is not possible 12\.Pregnant or lactating women. 13\. Any other person whom the principal investigator has determined to be unsuitable as a participant of the study. \*Warning symptoms list. 1\.Symptoms which first appeared after 50 years of age. 2\.Any rectal bleeding that has not undergone sufficient medical investigation (excluding that caused by known hemorrhoids). 3\.Diarrhea\-predominant IBS in which no colonoscopy investigation has been conducted. 4\.Unexplained weight loss without a change in eating habits. 5\.Nocturnal symptoms sufficient to cause insomnia. 6\.The presence of warning symptoms (anemia, inflammatory reactions, or fecal occult blood). 7\.Persons with a family history of colon cancer in a first\- or second\-degree relative (grandparents, parents, siblings, or children).

Outcomes

Primary Outcomes

Not specified

Similar Trials